Silverleafe Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Silverleafe Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 03, 2019	SELL	$61.87 - $69.38 $2.13 Million - $2.39 Million	-34,436 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$62.53 - $70.05 $1.4 Million - $1.57 Million	22,348 Added 184.88%	34,436 $2.24 Million
Q4 2018 Jan 04, 2019	BUY	$60.54 - $79.0 $446,119 - $582,151	7,369 Added 156.16%	12,088 $756,000
Q3 2018 Oct 05, 2018	BUY	$71.28 - $78.92 $49,967 - $55,322	701 Added 17.45%	4,719 $364,000
Q2 2018 Jul 09, 2018	BUY	$64.88 - $75.68 $260,687 - $304,082	4,018 New	4,018 $285,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.